178 related articles for article (PubMed ID: 34929414)
1. Association of KIR gene polymorphisms with COVID-19 disease.
Hajeer A; Jawdat D; Massadeh S; Aljawini N; Abedalthagafi MS; Arabi YM; Alaamery M
Clin Immunol; 2022 Jan; 234():108911. PubMed ID: 34929414
[TBL] [Abstract][Full Text] [Related]
2. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection.
Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A
PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002
[TBL] [Abstract][Full Text] [Related]
3. Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated With the Severity of Coronavirus Disease 2019.
Bernal E; Gimeno L; Alcaraz MJ; Quadeer AA; Moreno M; Martínez-Sánchez MV; Campillo JA; Gomez JM; Pelaez A; García E; Herranz M; Hernández-Olivo M; Martínez-Alfaro E; Alcaraz A; Muñoz Á; Cano A; McKay MR; Muro M; Minguela A
J Infect Dis; 2021 Jul; 224(2):229-240. PubMed ID: 33928374
[TBL] [Abstract][Full Text] [Related]
4. A model integrating Killer Immunoglobulin-like Receptor (KIR) haplotypes for risk prediction of COVID-19 clinical disease severity.
Beksac M; Akin HY; Gencer-Oncul EB; Yousefzadeh M; Cengiz Seval G; Gulten E; Akdemir Kalkan I; Cinar G; Memikoglu O; Karaagaoglu E; Dalva K
Immunogenetics; 2021 Dec; 73(6):449-458. PubMed ID: 34536086
[TBL] [Abstract][Full Text] [Related]
5. Positive association of Bx genotype, KIR2L5, KIR2DS5 and full-length KIR2DS4 with the risk of meningioma.
Barani S; Taghipour M; Ghaderi A
Immunobiology; 2020 Mar; 225(2):151900. PubMed ID: 31899050
[TBL] [Abstract][Full Text] [Related]
6. Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation.
Jafari D; Nafar M; Yekaninejad MS; Abdolvahabi R; Lesan Pezeshki M; Razaghi E; Amirzargar AA
Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):245-255. PubMed ID: 28732438
[TBL] [Abstract][Full Text] [Related]
7. HLA-DPB1*13:01 associates with enhanced, and KIR2DS4*001 with diminished protection from developing severe COVID-19.
Farias TDJ; Brugiapaglia S; Croci S; Magistroni P; Curcio C; Zguro K; Fallerini C; Fava F; Pettini F; Kichula KM; Pollock NR; Font-Porterias N; Palmer WH; Marin WM; Baldassarri M; Bruttini M; Hollenbach JA; Hendricks AE; Meloni I; Novelli F; ; Renieri A; Furini S; Norman PJ; Amoroso A
HLA; 2024 Jan; 103(1):e15251. PubMed ID: 37850268
[TBL] [Abstract][Full Text] [Related]
8. Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis.
Mahmoudi M; Fallahian F; Sobhani S; Ghoroghi S; Jamshidi A; Poursani S; Dolati M; Hosseinpour Z; Gharibdoost F
Clin Rheumatol; 2017 Apr; 36(4):853-862. PubMed ID: 28120169
[TBL] [Abstract][Full Text] [Related]
9. Genetic Predisposition to Unexplained Recurrent Pregnancy Loss: Killer Cell Immunoglobulin-Like Receptor Gene Polymorphisms as Potential Biomarkers.
Ay ME; Ay Öİ; Çayan FE; Tekin S; Karakaş Ü; Derici Yildirim D; Erdal ME
Genet Test Mol Biomarkers; 2019 Jan; 23(1):57-65. PubMed ID: 30585744
[TBL] [Abstract][Full Text] [Related]
10. Allelic Polymorphisms of
Ureshino H; Shindo T; Kojima H; Kusunoki Y; Miyazaki Y; Tanaka H; Saji H; Kawaguchi A; Kimura S
Cancer Immunol Res; 2018 Jun; 6(6):745-754. PubMed ID: 29695383
[TBL] [Abstract][Full Text] [Related]
11. The effects of killer cell immunoglobulin-like receptor (KIR) genes on susceptibility to HIV-1 infection in the Polish population.
Zwolińska K; Błachowicz O; Tomczyk T; Knysz B; Gąsiorowski J; Zalewska M; Orzechowska BU; Sochocka M; Piasecki E
Immunogenetics; 2016 May; 68(5):327-37. PubMed ID: 26888639
[TBL] [Abstract][Full Text] [Related]
12. Association of Functional Polymorphisms of KIR3DL1/DS1 With Behçet's Disease.
Castaño-Núñez Á; Montes-Cano MA; García-Lozano JR; Ortego-Centeno N; García-Hernández FJ; Espinosa G; Graña-Gil G; Sánchez-Bursón J; Juliá MR; Solans R; Blanco R; Barnosi-Marín AC; Gómez de la Torre R; Fanlo P; Rodríguez-Carballeira M; Rodríguez-Rodríguez L; Camps T; Castañeda S; Alegre-Sancho JJ; Martín J; González-Escribano MF
Front Immunol; 2019; 10():2755. PubMed ID: 31849952
[TBL] [Abstract][Full Text] [Related]
13. Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study.
Varbanova VP; Mihailova S; Naumova E; Mihaylova AP
Turk J Haematol; 2019 Nov; 36(4):238-246. PubMed ID: 31337191
[TBL] [Abstract][Full Text] [Related]
14. KIR3DL1/S1 genotypes and KIR2DS4 allelic variants in the AB KIR genotypes are associated with Plasmodium-positive individuals in malaria infection.
Taniguchi M; Kawabata M
Immunogenetics; 2009 Dec; 61(11-12):717-30. PubMed ID: 19859704
[TBL] [Abstract][Full Text] [Related]
15. Coronavirus-19 disease risk and protective factors associated with HLA/KIR polymorphisms in Ecuadorian patients residing in Madrid.
Balas A; Moreno-Hidalgo MÁ; de la Calle-Prieto F; Vicario JL; Arsuaga M; Trigo E; de Miguel-Buckley R; Bellón T; Díaz-Menéndez M
Hum Immunol; 2023 Nov; 84(11):571-577. PubMed ID: 37777360
[TBL] [Abstract][Full Text] [Related]
16. Killer cell immunoglobulin-like receptor (KIR) gene contents: Are they associated with cervical cancer?
Tembhurne AK; Maheshwari A; Warke H; Chaudhari H; Kerkar SC; Deodhar K; Rekhi B; Mania-Pramanik J
J Med Virol; 2023 Jan; 95(1):e27873. PubMed ID: 35593263
[TBL] [Abstract][Full Text] [Related]
17. Association of KIR2DS4 and its variant KIR1D with syphilis in a Chinese Han population.
Zhuang YL; Zhu CF; Zhang Y; Song YH; Wang DJ; Nie XM; Liu Y; Ren GJ
Int J Immunogenet; 2012 Apr; 39(2):114-8. PubMed ID: 22128817
[TBL] [Abstract][Full Text] [Related]
18. Activating and inhibitory killer cell immunoglobulin like receptors (KIR) genes are involved in an increased susceptibility to colorectal adenocarcinoma and protection against invasion and metastasis.
Barani S; Hosseini SV; Ghaderi A
Immunobiology; 2019 Sep; 224(5):681-686. PubMed ID: 31248612
[TBL] [Abstract][Full Text] [Related]
19. Contribution of genes for killer cell immunoglobulin-like receptors (KIR) to the susceptibility to chronic hepatitis C virus infection and to viremia.
Kuśnierczyk P; Mozer-Lisewska I; Zwolińska K; Kowala-Piaskowska AE; Bura M; Bereszyńska I; Pauli A; Żeromski J
Hum Immunol; 2015 Mar; 76(2-3):102-8. PubMed ID: 25636579
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of killer immunoglobulin-like receptors (KIRs) and HLA ligands in northeastern Thais.
Chaisri S; Kitcharoen K; Romphruk AV; Romphruk A; Witt CS; Leelayuwat C
Immunogenetics; 2013 Sep; 65(9):645-53. PubMed ID: 23812166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
